The Best of the AUA 2002: Basic science

Presented by Ralph Buttyan, PhD, Columbia-Presbyterian MedicalCenter, New York.

Related Content:

Drug Therapy
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria